Table 2.
No. Patients with Active TB | No. Diagnosed with True TB | TB Deaths | No. with true TB started on Treatment | No. without TB started on TB treatment | Total costa | Incremental costb | Total Effectiveness (YLG)c | Incremental Effectivness | Incremental Cost-effectiveness (ICER) - USD/YLG | |
---|---|---|---|---|---|---|---|---|---|---|
Clinical Diagnosis | 140 | 96 | 29 | 90 | 147 | 66769 | 0 | 22480 | 0 | 0 |
Clinical Diagnosis plus MODS | 140 | 117 | 26 | 108 | 163 | 95365 | 28596 | 22750 | 270 | 106 |
Clinical Practice plus Xpert | 140 | 115 | 24 | 110 | 163 | 105691 | 38922 | 22790 | 310 | 126 |
Treat All children presenting with suspected TB | 140 | 140 | 18 | 140 | 860 | 193662 | 126893 | 23170 | 690 | 184 |
Total cost: includes cost of diagnosis, treatment of true and false positives.
Incremental cost (and effectiveness): cost-effectiveness is relative to current clinical practice alone scenario (for example: $95,364.59-$66,769.04=an incremental cost of $28,595.55).
Total effectiveness reflects the underlying life expectancy of 54 years for 1000 kids applying a discount of 3%.